Cardiac Resynchronization Therapy in Older Patients: Age Is Just a Number, and Yet ….
作者信息
Kramer Daniel B, Steinhaus Daniel A
机构信息
Richard and Susan Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
出版信息
J Card Fail. 2016 Dec;22(12):978-980. doi: 10.1016/j.cardfail.2016.10.006. Epub 2016 Oct 17.
Abstract
摘要
相似文献
1
Cardiac Resynchronization Therapy in Older Patients: Age Is Just a Number, and Yet ….老年患者的心脏再同步治疗：年龄只是一个数字，然而……
J Card Fail. 2016 Dec;22(12):978-980. doi: 10.1016/j.cardfail.2016.10.006. Epub 2016 Oct 17.
2
Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure.植入式设备的投资回报率：轻度症状性心力衰竭的心脏再同步治疗
JACC Heart Fail. 2017 Mar;5(3):213-215. doi: 10.1016/j.jchf.2017.01.004.
3
eComment. Cardiac resynchronization therapy in cardiac surgery.电子评论。心脏手术中的心脏再同步治疗。
Interact Cardiovasc Thorac Surg. 2012 Nov;15(5):923-4. doi: 10.1093/icvts/ivs407.
4
More bad news for cardiac resynchronization therapy in atrial fibrillation patients: what to do?心房颤动患者心脏再同步治疗的更多坏消息：该怎么办？
J Cardiovasc Electrophysiol. 2013 Oct;24(10):1123-4. doi: 10.1111/jce.12242. Epub 2013 Sep 9.
5
The emerging role of cardiac resynchronization therapy in milder heart failure: are we implanting too late for response?心脏再同步治疗在轻度心力衰竭中日益凸显的作用：我们植入治疗是否过晚而无法取得疗效？
Curr Heart Fail Rep. 2012 Mar;9(1):51-6. doi: 10.1007/s11897-011-0075-3.
6
Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.心脏植入式电子设备治疗：永久性起搏器、植入式心脏复律除颤器和心脏再同步治疗装置。
Med Clin North Am. 2019 Sep;103(5):931-943. doi: 10.1016/j.mcna.2019.04.005. Epub 2019 Jul 5.
7
Effect of cardiac resynchronization therapy on quality of life: the best gets the least.心脏再同步治疗对生活质量的影响：最佳治疗却收获最少。
Europace. 2012 Nov;14(11):1537-9. doi: 10.1093/europace/eus265. Epub 2012 Oct 25.
8
Cardiac resynchronization therapy consensus guidelines: Evolution or revolution?心脏再同步治疗共识指南：是演进还是变革？
Int J Cardiol. 2018 Jun 15;261:142-143. doi: 10.1016/j.ijcard.2018.03.040.
9
To the Editor- The cost of cardiac resynchronization therapy generator replacement?致编辑——心脏再同步治疗发生器更换的费用？
Heart Rhythm. 2018 Mar;15(3):e35-e36. doi: 10.1016/j.hrthm.2017.12.008. Epub 2017 Dec 8.
10
Identifying and Addressing Gaps in the Use of Cardiac Resynchronization Therapy.识别并解决心脏再同步治疗应用中的差距
J Card Fail. 2020 Aug;26(8):739-741. doi: 10.1016/j.cardfail.2020.02.003. Epub 2020 Feb 26.
引用本文的文献
1
Mandates for Shared Decisions: Means to which Ends?共同决策的要求：手段服务于何种目的？
J Law Med Ethics. 2021;49(4):630-632. doi: 10.1017/jme.2021.86.
2
Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.使用和不使用植入式心脏复律除颤器的心脏再同步治疗中的机构层面差异与临床结局
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004763. doi: 10.1161/CIRCOUTCOMES.118.004763.
本文引用的文献
1
Mode of Death in Octogenarians Treated With Cardiac Resynchronization Therapy.接受心脏再同步治疗的八旬老人的死亡方式
J Card Fail. 2016 Dec;22(12):970-977. doi: 10.1016/j.cardfail.2016.09.023. Epub 2016 Oct 4.
2
Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.欧洲心脏病学会成员国心脏植入式电子设备的获取与临床应用以及介入性电生理手术：欧洲心律协会2016年报告
Europace. 2016 Aug;18 Suppl 3:iii1-iii79. doi: 10.1093/europace/euw244.
3
Geographic and Temporal Variation in Cardiac Implanted Electric Devices to Treat Heart Failure.用于治疗心力衰竭的心脏植入式电子装置的地理和时间差异。
J Am Heart Assoc. 2016 Jul 28;5(8):e003532. doi: 10.1161/JAHA.116.003532.
4
Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations.老年人植入式心脏转复除颤器：基本原理和特定与年龄相关的考虑因素。
Europace. 2015 Feb;17(2):174-86. doi: 10.1093/europace/euu296. Epub 2014 Dec 5.
5
Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.瑞典植入式电子设备的使用现状：来自瑞典起搏器和植入式心脏复律除颤器注册中心的数据。
Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21.
6
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗：系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.
7
Resynchronization: considering device-based cardiac therapy in older adults.再同步化：考虑在老年患者中应用器械心脏治疗。
J Am Geriatr Soc. 2013 Apr;61(4):615-21. doi: 10.1111/jgs.12174. Epub 2013 Mar 21.
8
Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?心力衰竭患者心脏再同步化和植入型心律转复除颤器治疗的死亡率降低：更新的荟萃分析。最近的证据是否改变了治疗标准？
J Card Fail. 2011 Oct;17(10):860-6. doi: 10.1016/j.cardfail.2011.06.372. Epub 2011 Jul 23.
9
Informed consent in cardiac resynchronization therapy: what should be said?心脏再同步治疗中的知情同意：应该告知哪些内容？
Circ Cardiovasc Qual Outcomes. 2011 Sep;4(5):573-7. doi: 10.1161/CIRCOUTCOMES.111.961680.
10
Cardiac care for older adults. Time for a new paradigm.老年人心血管护理。是时候采用新范式了。
J Am Coll Cardiol. 2011 May 3;57(18):1801-10. doi: 10.1016/j.jacc.2011.02.014.
Zotero 插件